Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ronacaleret in post-menopausal osteoporosis
NCT00471237Phase 2Terminated
- Sponsor
- GSK
- Start
- May 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of ronacaleret in osteoporosis, sponsored by GSK. Started May 2007; status: terminated.
02
Drugs
ronacaleret
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00471237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00471237.